After adjusting for age, sex, education, income, cancer site, and race, there was over a 6-fold increased risk of cancer mortality associated with the highest tertile of IL-6 (HR: 6.66, 95% CI: 2.70–16.43). This evidence concerns the gene IL6 and cancer.